Lixte Biotechnology Holdings Inc LIXT Q4 2024 Earnings Net Loss of 027 Per Share as Pipeline Progress Continues OMER Q1 2026 Earnings EPS Beats Estimates as Operating Expenses Decline But Stock Falls on Lack of Revenue BSAC Q1 2026 Earnings EPS Surpasses Estimates Shares Rally on Strong Performance ALNY Q1 2026 Earnings EPS Smashes Estimates While Shares Edge Lower PRTA Q1 2026 Earnings Biotech Surprises with Positive EPS on Milestone Gain Stock Rises UONE Q1 2026 Earnings Net Loss of 069 Per Share as Stock Drops 66 NMFCZ Q1 2026 Earnings Missed Estimates by Narrow Margin as EPS Comes in at 032 IOBT Q1 2025 Earnings Beating Estimates While Advancing Pipeline Milestones ATKR Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Execution KNTK Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines RXRX Q1 2026 Earnings EPS Beat Despite No Revenue Stock Slips 32 CRH Q1 2026 Earnings EPS Surprises to the Upside Amid Mixed Construction Demand Lockheed Martin Graham Stephans Bullish Outlook on Defense Giant Gains Relevance Amid Geopolitical Tensions SPRY Q1 2026 Earnings EPS Misses Expectations Stock Rises on Pipeline Progress Arhaus Q1 2026 Earnings EPS Beats Estimates Despite Revenue Headwinds Shares Rise 668 EIC Q4 2025 Earnings Narrow EPS Miss but Positive Stock Suggests Investor Confidence Vanguard Total International Stock Index Fund ETF VXUS Gains Attention as Graham Stephan Portfolio Pick AVX Q1 2026 Earnings Narrowing Loss in Core Operations Amid Quiet Quarter Arhaus Q1 2026 Earnings EPS Beats Estimates Despite Revenue Headwinds Shares Rise 668